6.22
price up icon4.36%   0.26
after-market Handel nachbörslich: 6.22
loading
Schlusskurs vom Vortag:
$5.96
Offen:
$5.93
24-Stunden-Volumen:
589.58K
Relative Volume:
2.36
Marktkapitalisierung:
$480.09M
Einnahmen:
$14.02M
Nettoeinkommen (Verlust:
$-84.03M
KGV:
-2.4297
EPS:
-2.56
Netto-Cashflow:
$-125.54M
1W Leistung:
+6.32%
1M Leistung:
+49.88%
6M Leistung:
+24.40%
1J Leistung:
+17.36%
1-Tages-Spanne:
Value
$5.81
$6.24
1-Wochen-Bereich:
Value
$5.52
$6.36
52-Wochen-Spanne:
Value
$3.85
$7.60

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name
Firmenname
Meiragtx Holdings Plc
Name
Telefon
(646) 490-2965
Name
Adresse
450 EAST 29TH STREET, NEW YORK, NY
Name
Mitarbeiter
387
Name
Twitter
@MeiraGTx
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
MGTX's Discussions on Twitter

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-10-23 Eingeleitet RBC Capital Mkts Outperform
2020-09-15 Fortgesetzt BofA Securities Buy
2019-09-03 Eingeleitet Piper Jaffray Overweight
2019-02-27 Bestätigt Chardan Capital Markets Buy
2018-07-03 Eingeleitet Barclays Overweight
2018-07-03 Eingeleitet BofA/Merrill Buy
Alle ansehen

Meiragtx Holdings Plc Aktie (MGTX) Neueste Nachrichten

pulisher
Nov 01, 2024

Dynamic range: the key to MeiraGTx’s quest to control genes with pills - BioCentury

Nov 01, 2024
pulisher
Oct 29, 2024

Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech

Oct 29, 2024
pulisher
Oct 28, 2024

Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity - BioWorld Online

Oct 28, 2024
pulisher
Oct 24, 2024

Gene Therapy Market Detailed Analysis and Forecast to 2031 - InsightAce Analytic

Oct 24, 2024
pulisher
Oct 22, 2024

MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress - The Manila Times

Oct 22, 2024
pulisher
Oct 21, 2024

High Growth Tech Stocks to Watch in October 2024 - Simply Wall St

Oct 21, 2024
pulisher
Oct 19, 2024

MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains? - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

(MGTX) Long Term Investment Analysis - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

Cell therapy weekly: US$225 million investment towards world-class research institute - RegMedNet

Oct 17, 2024
pulisher
Oct 16, 2024

MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study - Clinical Trials Arena

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings plc Inc. (MGTX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 16, 2024
pulisher
Oct 16, 2024

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

Items Tagged with 'glutamic acid decarboxylase' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Items Tagged with 'AAV-GAD' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Meiragtx looks to a phase III in Parkinson’s - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints - AOL

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx (MGTX) Sees Stock Surge After Clinical Results News - Stocks Telegraph

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx stock gains on Parkinson’s drug data (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

Investors in MeiraGTx Holdings (NASDAQ:MGTX) from three years ago are still down 75%, even after 13% gain this past week - Simply Wall St

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx reports positive Parkinson's gene therapy trial results By Investing.com - Investing.com UK

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease - StockTitan

Oct 15, 2024
pulisher
Oct 15, 2024

Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data - Yahoo Finance

Oct 15, 2024
pulisher
Oct 15, 2024

Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results - Benzinga

Oct 15, 2024
pulisher
Oct 12, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares - Investing.com

Oct 12, 2024
pulisher
Oct 11, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 09, 2024

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference - The Manila Times

Oct 09, 2024
pulisher
Oct 07, 2024

MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook - Yahoo Finance

Oct 07, 2024
pulisher
Oct 03, 2024

DT Midstream (NYSE:DTM) Price Target Increased to $85.00 by Analysts at Barclays - Defense World

Oct 03, 2024
pulisher
Sep 30, 2024

MeiraGTx's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 27, 2024

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? - Yahoo Finance

Sep 27, 2024
pulisher
Sep 25, 2024

Bank of New York Mellon Corp Sells 14,485 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Sep 25, 2024
pulisher
Sep 23, 2024

Beck Capital Management LLC Has $2.07 Million Stock Holdings in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Financial Metrics Check: Macrogenics Inc (MGNX)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Leonardo Increases Stake In GEM Elettronica To 65% With EUR 16 Mln Investment - XM

Sep 23, 2024
pulisher
Sep 23, 2024

MyCelx drops as revenue guidance pushed on order delay - Proactive Investors USA

Sep 23, 2024
pulisher
Sep 22, 2024

Sei Investments Co. Decreases Stock Position in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Argent Trust Co Purchases New Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

MGO Global regains compliance with Nasdaq equity rule - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Macrogenics Inc [MGNX] Records 200-Day SMA of $9.69 - Knox Daily

Sep 20, 2024
pulisher
Sep 20, 2024

MeiraGTx (NASDAQ:MGTX) and LadRx (OTCMKTS:CYTR) Financial Contrast - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

MGNX Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. (MGNX) Investors of Filing Deadline in Class Action Lawsuit - PR Newswire

Sep 19, 2024
pulisher
Sep 18, 2024

The Gross Law Firm Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MGNX - EIN News

Sep 18, 2024
pulisher
Sep 18, 2024

Grinta completes full divestment of Moncler shares - XM

Sep 18, 2024
pulisher
Sep 17, 2024

MyEG Rises 8.6 Pct In Early Trade - BERNAMA

Sep 17, 2024
pulisher
Sep 17, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc.MGX - PR Newswire

Sep 17, 2024
pulisher
Sep 17, 2024

Globus Medical director Ann D. Rhoads sells shares worth over $1 million - Investing.com

Sep 17, 2024
pulisher
Sep 17, 2024

MacroGenics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMGNX - Marketscreener.com

Sep 17, 2024
pulisher
Sep 09, 2024

Exploring Three High Growth Tech Stocks in the United States - Simply Wall St

Sep 09, 2024

Finanzdaten der Meiragtx Holdings Plc-Aktie (MGTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):